Evaluation of technetium Tc 99m–labeled biotin for scintigraphic detection of soft tissue inflammation in horses

Lauren G. Kleine Department of Clinical Sciences, Cummings School of Veterinary Medicine, Tufts University, North Grafton, MA 01536.

Search for other papers by Lauren G. Kleine in
Current site
Google Scholar
PubMed
Close
 DVM
,
Mauricio Solano Department of Clinical Sciences, Cummings School of Veterinary Medicine, Tufts University, North Grafton, MA 01536.

Search for other papers by Mauricio Solano in
Current site
Google Scholar
PubMed
Close
 MV
,
Mary Rusckowski Department of Radiology, University of Massachusetts Medical School, Worcester, MA 01655.

Search for other papers by Mary Rusckowski in
Current site
Google Scholar
PubMed
Close
 PhD
,
Kathleen E. Hunt Department of Clinical Sciences, Cummings School of Veterinary Medicine, Tufts University, North Grafton, MA 01536.

Search for other papers by Kathleen E. Hunt in
Current site
Google Scholar
PubMed
Close
 BS
,
Karen L. Johnson Department of Clinical Sciences, Cummings School of Veterinary Medicine, Tufts University, North Grafton, MA 01536.

Search for other papers by Karen L. Johnson in
Current site
Google Scholar
PubMed
Close
 BS
, and
Carl A. Kirker-Head Department of Clinical Sciences, Cummings School of Veterinary Medicine, Tufts University, North Grafton, MA 01536.

Search for other papers by Carl A. Kirker-Head in
Current site
Google Scholar
PubMed
Close
 MA, VetMB

Abstract

Objective—To evaluate the use of technetium Tc 99m–labeled EDTA-biotin monomer (99mTc-EB1) as a scintigraphic imaging agent for soft tissue inflammatory lesions in horses.

Animals—6 healthy adult horses.

Procedures—First (phase 1), the agent's safety and blood-tissue clearance and an appropriate imaging protocol were determined in 6 horses. Each horse was injected with 99mTc-EB1 (1.1 GBq, IV, once); images were acquired at intervals during the following 24-hour period. Subsequently (phase 2), inflammation was induced via injection of 200 mg (10 mL) of mepivacaine (0.4 mg/kg) into the right neck musculature and perineurally in the proximal palmar metacarpal region of the right forelimb of 2 horses. Six hours after mepivacaine injection, 99mTc-EB1 (2.2 GBq, IV, once) was administered; 8 hours after injection, comparative soft tissue images were acquired after administration of technetium 99mTc-hydroxymethylene diphosphonate (99mTc-HDP; 7.4 GBq, IV, once).

Results—After injections of 99mTc-EB1, physical examinations, CBCs, and serum biochemical analyses revealed no abnormalities in any horse. Blood clearance of 99mTc-EB1 was rapid (A phase, 2.2 minutes; β phase, 58 minutes). Soft tissue uptake of 99mTc-EB1 was immediate and persisted for as long as 4 hours after injection. At 6 hours after IM and perineural mepivacaine injections, mepivacaine-induced inflammation was detectable by use of 99mTc-EB1.

Conclusions and Clinical Relevance—Results indicated that 99mTc-EB1 is safe for use in horses and can identify soft tissue inflammation without concurrent uptake in bone. Compared with 99mTc-HDP administration, use of 99mTc-EB1 extended the duration of soft tissue scintigraphic image acquisition.

Abstract

Objective—To evaluate the use of technetium Tc 99m–labeled EDTA-biotin monomer (99mTc-EB1) as a scintigraphic imaging agent for soft tissue inflammatory lesions in horses.

Animals—6 healthy adult horses.

Procedures—First (phase 1), the agent's safety and blood-tissue clearance and an appropriate imaging protocol were determined in 6 horses. Each horse was injected with 99mTc-EB1 (1.1 GBq, IV, once); images were acquired at intervals during the following 24-hour period. Subsequently (phase 2), inflammation was induced via injection of 200 mg (10 mL) of mepivacaine (0.4 mg/kg) into the right neck musculature and perineurally in the proximal palmar metacarpal region of the right forelimb of 2 horses. Six hours after mepivacaine injection, 99mTc-EB1 (2.2 GBq, IV, once) was administered; 8 hours after injection, comparative soft tissue images were acquired after administration of technetium 99mTc-hydroxymethylene diphosphonate (99mTc-HDP; 7.4 GBq, IV, once).

Results—After injections of 99mTc-EB1, physical examinations, CBCs, and serum biochemical analyses revealed no abnormalities in any horse. Blood clearance of 99mTc-EB1 was rapid (A phase, 2.2 minutes; β phase, 58 minutes). Soft tissue uptake of 99mTc-EB1 was immediate and persisted for as long as 4 hours after injection. At 6 hours after IM and perineural mepivacaine injections, mepivacaine-induced inflammation was detectable by use of 99mTc-EB1.

Conclusions and Clinical Relevance—Results indicated that 99mTc-EB1 is safe for use in horses and can identify soft tissue inflammation without concurrent uptake in bone. Compared with 99mTc-HDP administration, use of 99mTc-EB1 extended the duration of soft tissue scintigraphic image acquisition.

Contributor Notes

Ms. Johnson's present address is Department of Radiology, University of Massachusetts Medical School, Worcester, MA 01655.

Presented in abstract form at the American College of Veterinary Surgeons Symposium, Washington, DC, October 2006, and the 52nd Annual Convention of the American Association of Equine Practitioners, San Antonio, December 2006.

Supported by the Hospital for Large Animals, Department of Clinical Sciences, and Orthopaedic Research Laboratory of Tufts University College of Veterinary Medicine.

Address correspondence to Dr. Kleine.
  • 1.

    Ueltschi G. Bone and joint imaging with 99mTc–labeled phosphates as a new aid in veterinary orthopedics. J Am Vet Radiol Soc 1977;18:8084.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 2.

    Devous MD Sr, Twardock AR. Techniques and applications of nuclear medicine in the diagnosis of equine lameness. J Am Vet Med Assoc 1984;184:318325.

    • Search Google Scholar
    • Export Citation
  • 3.

    Chambers MD, Martinelli MJ, Baker GJ, et al. Nuclear medicine for diagnosis of lameness in horses. J Am Vet Med Assoc 1995;206:792796.

  • 4.

    Koblik PD, Hornof WJ, Seeherman HJ. Scintigraphic appearance of stress-induced trauma of the dorsal cortex of the third metacarpal bone in racing Thoroughbred horses: 121 cases (1978–1986). J Am Vet Med Assoc 1988;192:390395.

    • Search Google Scholar
    • Export Citation
  • 5.

    Lamb CR, Koblik PD. Scintigraphic evaluation of skeletal disease and its application to the horse. Vet Radiol 1988;29:1627.

  • 6.

    Trout DR, Hornof WJ, O'Brien TR. Soft tissue- and bone-phase scintigraphy for diagnosis of navicular disease in horses. J Am Vet Med Assoc 1991;198:7377.

    • Search Google Scholar
    • Export Citation
  • 7.

    Hoskinson JJ. Equine nuclear scintigraphy. Indications, uses, and techniques. Vet Clin North Am Equine Pract 2001;17:6374.

  • 8.

    Graham JP, Roberts GD. Equine skeletal scintigraphy. In: Wells D, ed. Textbook of veterinary nuclear medicine. 2nd ed. Knoxville, Tenn: American College of Veterinary Radiology, 2006;165180.

    • Search Google Scholar
    • Export Citation
  • 9.

    Steckel RR. The role of scintigraphy in the lameness evaluation. Vet Clin North Am Equine Pract 1991;7:207239.

  • 10.

    Tucker RL, Broome M. Scintigraphic imaging of inflammation and infection. In: Wells D, ed. Textbook of veterinary nuclear medicine. 2nd ed. Knoxville, Tenn: American College of Veterinary Radiology, 2006;363376.

    • Search Google Scholar
    • Export Citation
  • 11.

    Koblik PD, Lofstedt J, Jakowski RM, et al. Use of 111In-labeled autologous leukocytes to image an abdominal abscess in a horse. J Am Vet Med Assoc 1985;186:13191322.

    • Search Google Scholar
    • Export Citation
  • 12.

    Hnatowich DJ, Virzi F, Rusckowski M. Investigations of avidin and biotin for imaging applications. J Nucl Med 1987;28:12941302.

  • 13.

    Rusckowski M, Fritz B, Hnatowich DJ. Localization of infection using streptavidin and biotin: an alternative to nonspecific polyclonal immunoglobulin. J Nucl Med 1992;33:18101815.

    • Search Google Scholar
    • Export Citation
  • 14.

    Hnatowich DJ, Fritz B, Virzi F, et al. Improved tumor localization with (strept) avidin and labeled biotin as a substitute for antibody. Nucl Med Biol 1993;20:189195.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 15.

    Rusckowski M, Fogarasi M, Virzi F, et al. Influence of endogenous biotin on the biodistribution of labeled biotin derivatives in mice. Nucl Med Commun 1995;16:3846.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 16.

    Rusckowski M, Paganelli G, Hnatowich DJ, et al. Imaging osteomyelitis with strepavidin and indium-111-labeled biotin. J Nucl Med 1996;37:16551662.

    • Search Google Scholar
    • Export Citation
  • 17.

    Lamb CR. Non-skeletal distribution of bone seeking radiopharmaceuticals. Vet Radiol 1990;31:246253.

  • 18.

    Driver AJ. Radiopharmacy. In: Rossdale PD, ed. Equine scintigraphy. Newmarket, England: Equine Veterinary Journal, 2003;2532.

  • 19.

    Schwarz SW, Anderson CJ, Downer JB. Radiochemistry and radiopharmacy. In: Bernier DR, Christian PE, Langan JK, eds. Nuclear medicine technology and techniques. 4th ed. St Louis: Mosby, 1997;160183.

    • Search Google Scholar
    • Export Citation
  • 20.

    Allhands RV, Twardock AR, Boero MJ. Uptake of 99mTc-MDP in muscle associated with a peripheral nerve block. Vet Radiol 1987;28:181184.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 21.

    Benoit PW, Belt WD. Some effects of local anesthetic agents on skeletal muscle. Exp Neurol 1972;34:264278.

  • 22.

    Trout DR, Hornof WJ, Liskey CC, et al. The effects of regional perineural anesthesia on soft tissue and bone phase scintigraphy in the horse. Vet Radiol 1991;32:140144.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 23.

    Gaughan EM, Wallace RJ, Kallfelz FA. Local anesthetics and nuclear medical bone images of the equine forelimb. Vet Surg 1990;19:131135.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 24.

    Silberstein EB, Francis MD, Tofe AJ, et al. Distribution of 99mTcSn-diphosphonate and free 99mTc pertechnetate in selected soft and hard tissues. J Nucl Med 1975;16:5861.

    • Search Google Scholar
    • Export Citation
  • 25.

    Planchon CA, Donadieu AM, Perez R, et al. Calcium heparinate induced extraosseous uptake in bone scanning. Eur J Nucl Med 1983;8:113117.

  • 26.

    Valberg SJ, Dyson SJ. Skeletal muscle and lameness. In: Ross MW, Dyson SJ, ed. Diagnosis and management of lameness in the horse. St Louis: Saunders, 2003;723743.

    • Search Google Scholar
    • Export Citation

Advertisement